Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Edith Illescas"'
Autor:
María Victoria Castro, Gastón Alexis Barbero, María Belén Villanueva, Luca Grumolato, Jérémie Nsengimana, Julia Newton-Bishop, Edith Illescas, María Josefina Quezada, Pablo Lopez-Bergami
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-15 (2021)
Abstract Background Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a Wnt5a receptor aberrantly expressed in cancer that was shown to either suppress or promote carcinogenesis in different tumor types. Our goal was to study the role of ROR2
Externí odkaz:
https://doaj.org/article/4aa18ad8bb6d4dfa887f300feb49a3f7
Autor:
Pablo Lopez-Bergami, María Belén Villanueva, María Victoria Castro, Jérémie Nsengimana, María Josefina Quezada, Edith Illescas, Luca Grumolato, Gastón Barbero, Julia Newton-Bishop
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-15 (2021)
Journal of Biomedical Science
Journal of Biomedical Science
Background Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a Wnt5a receptor aberrantly expressed in cancer that was shown to either suppress or promote carcinogenesis in different tumor types. Our goal was to study the role of ROR2 in melan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac46508a885f04849f63374e2eb565a
https://doaj.org/article/4aa18ad8bb6d4dfa887f300feb49a3f7
https://doaj.org/article/4aa18ad8bb6d4dfa887f300feb49a3f7
Publikováno v:
Oncología Clínica. 25
Las mujeres con síndrome hereditario de cáncer de mama y de ovario representan un grupo único de pacientes, con riesgo de desarrollar cáncer de mama y ovario, entre otros tumores, a edades tempranas. Este síndrome se asocia a mutaciones de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50746f995c68efbca815b35ad29ab404
https://doi.org/10.56969/oc.v25i1.27
https://doi.org/10.56969/oc.v25i1.27
Autor:
María Victoria Castro, Gastón Alexis Barbero, Paula Máscolo, María Belén Villanueva, Jérémie Nsengimana, Julia Newton-Bishop, Edith Illescas, María Josefina Quezada, Pablo Lopez-Bergami
Publikováno v:
J Cell Commun Signal
Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a protein with important functions during embryogenesis that is dysregulated in human cancer. An intriguing feature of this receptor is that it plays opposite roles in different tumor types ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86b420c0ef834e96402ecab5ace3340e
https://pubmed.ncbi.nlm.nih.gov/35723796
https://pubmed.ncbi.nlm.nih.gov/35723796
Autor:
Natalia Fernández, Edith Illescas, Gastón Barbero, Pablo Lopez-Bergami, María Josefina Quezada, María Victoria Castro, María Belén Villanueva, María Elisa Picco
Publikováno v:
Cancers, Vol 13, Iss 78, p 78 (2021)
Cancers
Volume 13
Issue 1
Cancers
Volume 13
Issue 1
Simple Summary BCL2L10 is the sixth and less studied protein from the group of Bcl-2 anti-apoptotic proteins. These proteins are important therapeutic targets since they convey resistance to anticancer regimens. We describe here for the first time th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d61c0d2a71143be1704257eacd890b29
https://www.mdpi.com/2072-6694/13/1/78
https://www.mdpi.com/2072-6694/13/1/78
Autor:
Gastón Barbero, Pablo Lopez-Bergami, María Victoria Castro, María Belén Villanueva, Edith Illescas, Julia Newton-Bishop, María Josefina Quezada, Jérémie Nsengimana
PurposeReceptor tyrosine kinase-like orphan receptor 2 (ROR2) has been shown to play opposite roles in the progression of different tumor types. In melanoma, ROR2 was shown to associate with a more invasive phenotype and to contribute to experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7e4aac3ed74129caa1312b06a31958e
https://doi.org/10.21203/rs.3.rs-1050315/v1
https://doi.org/10.21203/rs.3.rs-1050315/v1
Publikováno v:
Oncología Clínica. 20
La mayoría de los carcinomas colorrectales (CRCs - colorectal cancer) se originan de lesiones pre-neoplásicas desde una hiperplasia y/o adenoma que inicialmente son benignos, pero muchos de ellos progresan a carcinoma. Esta transformación, de u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9056dd3819505590b11b5f2bb6c61134
https://doi.org/10.56969/oc.v20i1.107
https://doi.org/10.56969/oc.v20i1.107